drugset / Trial / NCT07599761

A Phase 1 Study to Assess the Effect of Itraconazole on ABBV-722 in Healthy Adult Participants

NCT07599761 ↗

Phase 1 Completed 12 enrolled AbbVie
NaSingle-groupOpen-labelBasic science

Summary

The objective of this study is to assess the effect of repeated doses of itraconazole on the single dose pharmacokinetics (PK) of ABBV-722.

Timeline

Start
2026-05-07
Primary completion
2026-09-03
Completion
2026-09-03

Drugs

EvaluationDrugModalityDoseRoute
Subject ABBV-722 Unknown — Oral
Subject Itraconazole Small molecule — Oral

Indications

No indication recorded.